[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100491135":3},{"organization":4,"outcomesModule":7,"designInfo":16,"detailedDescription":11,"studyPopulation":19,"armGroups":11,"interventions":11,"overallOfficials":20,"centralContacts":24,"locations":11,"responsibleParty":29,"collaborators":11,"id":31,"slug":11,"hasResults":32,"nctId":33,"briefTitle":34,"officialTitle":35,"acronym":11,"eligibilityCriteria":36,"healthyVolunteers":32,"sex":37,"minAge":38,"maxAge":39,"enrollmentInfo":40,"targetDuration":11,"studyType":43,"phases":11,"briefSummary":44,"conditions":45,"keywords":48,"overallStatus":49,"whyStopped":11,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":11},{"fullName":5,"class":6},"Power Life Sciences Inc.","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":11,"otherOutcomes":11},[9,13],{"measure":10,"description":11,"timeFrame":12},"Number of patients who decide to enroll in a migraine clinical trial",null,"3 months",{"measure":14,"description":11,"timeFrame":15},"Rate of patients who remain in migraine clinical trial to trial completion","12 months",{"allocation":11,"interventionModel":11,"interventionModelDescription":11,"primaryPurpose":11,"observationalModel":17,"timePerspective":18,"maskingInfo":11},"CASE_CROSSOVER","PROSPECTIVE","Patients with migraine who are actively considering enrolling in an interventional clinical trial for said condition, but have not yet completed enrollment and randomization phases in said clinical trial.",[21],{"name":22,"affiliation":5,"role":23},"Michael B Gill","STUDY_DIRECTOR",[25],{"name":22,"role":26,"phone":27,"phoneExt":11,"email":28},"CONTACT","(415) 900-4227","bask@withpower.com",{"type":30,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100491135",false,"NCT05675189","Exploring Clinical Trial Experiences of Patients With Migraine","An In Depth Study Examining Patterns in the Clinical Trial Experiences of Migraine Patients","Inclusion Criteria:\n\n* Patient is a minimum of 18 years of age\n* Patient has been diagnosed with a type of migraine\n* Patient plans to participate in an interventional clinical trial for the condition of migraine\n* Patient has access to a home internet connection in order to provide regular updates through the course of the study\n\nExclusion Criteria:\n\n* Patient has an ECOG score of 4 or higher\n* Patient is not able to provide consistent digital updates as per study requirements\n* Patient does not complete or agree to terms outlined in the Informed Consent Form","ALL","18 Years","65 Years",{"count":41,"type":42},500,"ESTIMATED","OBSERVATIONAL","Clinical study participation has historically been heavily biased toward specific demographics.\n\nThis study will invite several participants to gather a wide range of information on clinical trial experiences for migraine patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of migraine.\n\nPeople with migraine who are invited to take part in medical research will benefit from the analysis of the data.",[46,47],"Migraine","Migraine Disorders",[46],"NOT_YET_RECRUITING","2024-02-23",{"date":52,"type":53},"2024-02-26","ACTUAL",{"date":55,"type":42},"2025-01",{"date":57,"type":42},"2027-01",{"name":5,"class":6}]